Facility

AbbVie Inc.

2 recall(s) on record — most severe on record: Class II.

Key facts

2recalls · worst Class II

—inspections in our data

—warning letters in our data

Recalls are listed for the parent company: openFDA recall records do not name a facility. How we attribute records

FDA Establishment Identifier (FEI)	3004217756
Establishment type	Manufacture Medical Device
Location	475 W Vaughn St Tempe, AZ, US 85283
Registration status	Active · expires 2026
Parent company	AbbVie Inc. (owner-operator 10046068)
Brand names	SmartDose

Activity by year

Recalls (2)

Devices registered here (1)

On-Body Injector
Product code QLF (opens in a new tab) · Class II · General Hospital · 21 CFR 880.5860

Recalls & enforcement

Class IITerminated2017-04-27
Class IITerminated2016-11-22
AbbVie is issuing an urgent field correction notification due to an increased number of reports of disconnections of the AbbVie 20FR PEG tube from the Y-connectors.

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “AbbVie Inc. (FEI 3004217756) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3004217756-abbvie-inc/

Not open yet

Alerts for AbbVie Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.